Dataset from A Phase 4, Randomized, Double-Blind, Multicenter, Placebo-controlled, Parallel Group Study Evaluating the Safety and Efficacy of SPD489 on Executive Function (Self-Regulation) Behaviors in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD) Reporting Clinically Significant Impairment of Real-World Executive Function Behavior.
收藏NIAID Data Ecosystem2026-05-10 收录
下载链接：
https://doi.org/10.25934/PR00007905
下载链接
链接失效反馈官方服务：
资源简介：
The primary objective of the study is to evaluate the efficacy of SPD489 compared to placebo
on executive function (self-regulation) behaviors in adults with ADHD who report clinically
significant impairment of executive function behavior in their everyday environment, as
measured by the self-report Behavior Rating Inventory of Executive Function - Adult Version
(BRIEF-A) Global Executive Composite (GEC) T-score.
创建时间：
2026-03-25
